Results 141 to 150 of about 7,044 (182)

Lipoxin A₄ yields an electrophilic 15-oxo metabolite that mediates FPR2 receptor-independent anti-inflammatory signaling. [PDF]

J Lipid Res
Koudelka A, Buchan GJ, Cechova V, O'Brien JP, Stevenson ER, Uvalle CE, Liu H, Woodcock SR, Mullett SJ, Zhang C, Freeman BA, Gelhaus SL.   +11 more
europepmc   +1 more source

Inflammation dynamics modulate periodontal stem cell fate and function. [PDF]

Front Immunol
Alves T, Alvarez-Rivas C, Mahatumarat N, Kantarci A.   +3 more
europepmc   +1 more source

Lipoxin A₄ improves cardiac remodeling and function in diabetes-associated cardiac dysfunction. [PDF]

Cardiovasc Diabetol
Fu T, Mohan M, Bose M, Brennan EP, Kiriazis H, Deo M, Nowell CJ, Godson C, Cooper ME, Zhao P, Kemp-Harper BK, Woodman OL, Ritchie RH, Kantharidis P, Qin CX.   +14 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Anti-inflammatory circuitry: Lipoxin, aspirin-triggered lipoxins and their receptor ALX

Prostaglandins, Leukotrienes and Essential Fatty Acids, 2005
Endogenous chemical mediators or autacoids play key roles in controlling inflammation and its programmed resolution. Among them, it is known that lipoxins (LX) and aspirin-triggered LX (ATL) evoke bioactions in a range of physiologic and pathophysiologic processes and serve as endogenous lipid/chemical mediators that stop neutrophilic infiltration and ...
Nan, Chiang, Makoto, Arita, Charles N, Serhan   +2 more
openaire   +2 more sources

Taking insult from injury: Lipoxins and lipoxin receptor agonists and phagocytosis of apoptotic cells

Prostaglandins, Leukotrienes and Essential Fatty Acids, 2005
Phagocytic clearance of apoptotic cells plays a pivotal role in the resolution of inflammation. Recent evidence has shown that such processes can be regulated by endogenous mediators, suggesting that specific mimetics may have therapeutic potential in chronic inflammation and autoimmune disorders.
Paola, Maderna, Catherine, Godson
openaire   +2 more sources

Lipoxin A4 Receptor Activation Is Distinct from That of the Formyl Peptide Receptor in Myeloid Cells: Inhibition of CD11/18 Expression by Lipoxin A4-Lipoxin A4 Receptor Interaction

Biochemistry, 1995
Lipoxin A4 (LXA4) interacts with high-affinity receptors in human neutrophils and differentiated HL-60 cells. Recently, we characterized a myeloid-derived cDNA that encodes a LXA4 high-affinity receptor (LXA4R) [Fiore, S., Maddox, J. F., Perez, H. D., and Serhan, C. N. (1994) J. Exp. Med.
S, Fiore, C N, Serhan
openaire   +2 more sources

Lipoxin A ₄ is a novel estrogen receptor modulator

The FASEB Journal, 2011
ABSTRACT Inflammation is intimately linked with naturally occurring remodeling events in the endometrium. Lipoxins comprise a group of short‐lived, non‐classic eicosanoids possessing potent anti‐inflammatory and proresolution properties. In the present study, we investigated the role of lipoxin A
Russell Ronan, Gori Ilaria, Pellegrini Chiara, Kumar Rajesh, Achtari Chahin, Canny Geraldine O   +5 more
openaire   +2 more sources

Differential regulation of monocytic expression of leukotriene and lipoxin receptors

Prostaglandins & Other Lipid Mediators, 2015
Lipoxygenase pathway yields both pro-inflammatory leukotrienes and pro-resolving lipoxins. The aim of the present study was to determine the effects of T-lymphocytes and pro-inflammatory stimuli on the expression levels of the lipoxin FPR2/ALX receptor, and the leukotriene BLT1 receptor in monocytes and macrophages, and to characterize LXA4-induced ...
Marcelo Heron, Petri, Silke, Thul, Olga, Ovchinnikova, Magnus, Bäck   +3 more
openaire   +2 more sources